Not applicableStudy completedNCT00743054What this trial is testingMicroRNA Expression in Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Sun Yat-sen University 50
Not applicableStudy completedNCT00895674What this trial is testingPatient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With NexavarWho this might be right forCarcinoma, Renal CellCarcinoma, Renal Cell (Advanced) Bayer 2,840
Early research (Phase 1)Study completedNCT01334073What this trial is testingStudy of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsWho this might be right forMalignant Advanced Solid TumorsCarcinoma, Renal Cell University Hospital, Bordeaux 19
Testing effectiveness (Phase 2)Study completedNCT00445042What this trial is testingSafety and Toxicity Study of Sorafenib in Patients With Kidney CancerWho this might be right forCarcinoma, Renal Cell The Methodist Hospital Research Institute 71
Early research (Phase 1)Study completedNCT02890069What this trial is testingPDR001 in Combination With LCL161, Everolimus or PanobinostatWho this might be right forColorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Novartis Pharmaceuticals 298
Testing effectiveness (Phase 2)Looking for participantsNCT03972657What this trial is testingA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsWho this might be right forMetastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC) Regeneron Pharmaceuticals 345
Testing effectiveness (Phase 2)Ended earlyNCT01391130What this trial is testingLY2510924 and Sunitinib in Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma Eli Lilly and Company 110
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT03945773What this trial is testingStudy of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint InhibitorsWho this might be right forLocally Advanced or Metastatic Renal Cell Carcinoma Ipsen 127
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT01689766What this trial is testingStudy Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Endocyte 150
Not applicableStudy completedNCT05823545What this trial is testingAssessment of Complications in Patients Who Underwent LPN According to the CCIWho this might be right forRenal CancerSurgery-Complications Samsun Liv Hospital 62
Large-scale testing (Phase 3)Looking for participantsNCT03755739What this trial is testingTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsWho this might be right forHepatocarcinomaLung CancerMelanoma+7 more Second Affiliated Hospital of Guangzhou Medical University 200
Not applicableStudy completedNCT01553175What this trial is testingStudying Gene Expression in Samples From Patients With Rhabdoid TumorsWho this might be right forBrain and Central Nervous System TumorsKidney Cancer Children's Oncology Group 25
Not applicableLooking for participantsNCT06290427What this trial is testingComparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)Who this might be right forRenal Carcinoma Azienda Ospedaliera Universitaria Integrata Verona 30
Early research (Phase 1)Active Not RecruitingNCT05614102What this trial is testingA First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bayer 284
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07101900What this trial is testing68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT03991130What this trial is testingHigh Dose IL-2 in Combination With Anti-PD-1Who this might be right forMelanomaRenal Cell Carcinoma, Metastatic Gregory Daniels 6
Large-scale testing (Phase 3)Study completedNCT03138512What this trial is testingA Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a KidneyWho this might be right forCarcinoma, Renal Cell Bristol-Myers Squibb 1,641